Raydiant Oximetry
Founded Year
2016Stage
Grant - II | AliveTotal Raised
$24.25MLast Raised
$1M | 1 day agoMosaic Score The Mosaic Score is an algorithm that measures the overall financial health and market potential of private companies.
+198 points in the past 30 days
About Raydiant Oximetry
Raydiant Oximetry focuses on improving maternal-fetal medicine by developing noninvasive sensor technology for childbirth. Its main product, Lumerah, is a fetal pulse oximeter designed to measure fetal oxygen levels accurately and reduce unnecessary cesarean deliveries. The company primarily serves the healthcare sector, offering tools for obstetric providers to better evaluate fetal well-being during labor. It was founded in 2016 and is based in San Ramon, California.
Loading...
Loading...
Research containing Raydiant Oximetry
Get data-driven expert analysis from the CB Insights Intelligence Unit.
CB Insights Intelligence Analysts have mentioned Raydiant Oximetry in 3 CB Insights research briefs, most recently on Mar 28, 2024.
Mar 28, 2024
The femtech market map
Expert Collections containing Raydiant Oximetry
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Raydiant Oximetry is included in 2 Expert Collections, including Digital Health.
Digital Health
11,075 items
The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.
Women's Health Tech
585 items
This collection includes companies applying technology to address a spectrum of physical, mental, and social well-being concerns specific to women. Examples include companies in reproductive health, maternal care, fertility tracking, and menopause support.
Raydiant Oximetry Patents
Raydiant Oximetry has filed 17 patents.
The 3 most popular patent topics include:
- respiratory physiology
- blood
- medical tests
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
12/28/2018 | 9/3/2024 | Blood, Respiratory physiology, Anesthesia, Respiratory therapy, Medical testing equipment | Grant |
Application Date | 12/28/2018 |
|---|---|
Grant Date | 9/3/2024 |
Title | |
Related Topics | Blood, Respiratory physiology, Anesthesia, Respiratory therapy, Medical testing equipment |
Status | Grant |
Latest Raydiant Oximetry News
Sep 24, 2024
News Provided By Share This Article SAN RAMON, CA, UNITED STATES, September 24, 2024 / EINPresswire.com / -- Raydiant Oximetry, Inc., a clinical-stage medical device company developing innovations to keep mothers and babies safe during childbirth, has announced the receipt of a $1 million grant from the Bill & Melinda Gates Foundation. The grant will support the development of Raydiant’s Lumerah™ technology, a non-invasive fetal pulse oximeter designed to enhance the detection of fetal distress during childbirth. Lumerah™ measures fetal blood oxygen saturation to provide real-time insights during labor and delivery. The technology recently received breakthrough device designation from the U.S. Food and Drug Administration (FDA) for expedited review. It has also gained Investigational Device Exemption (IDE) approval to begin an Early Feasibility Study (EFS) involving pregnant women in labor. The first participant was enrolled on May 15, 2024. The grant will be used to leverage data from the EFS to further refine the Lumerah™ technology, preparing it for clinical studies in low- and middle-income countries where it has the potential to significantly improve childbirth outcomes. “We invested in Raydiant because of the opportunity Lumerah has to materially impact maternal health globally,” said Annie Theriault, Managing Partner of Cross Border Impact Ventures. Raydiant is establishing an Impact Advisory Committee to guide its global strategy and oversee resource allocation, ensuring the technology's maximum global impact. The committee will include representatives from the Bill & Melinda Gates Foundation as well as Cross Border Impact Ventures. “We are honored to receive this grant from the Bill & Melinda Gates Foundation,” said Neil P. Ray, MD, founder and CEO of Raydiant Oximetry. “We look forward to collaborating with their team to extend our global reach and make a lasting difference in maternal and fetal health worldwide.” About Raydiant Oximetry, Inc. Raydiant Oximetry is a venture-backed, clinical-stage company dedicated to improving outcomes for mothers and babies during childbirth. The company was founded by Neil P. Ray, MD, a pediatric anesthesiologist, to find a solution to the pervasive problem of identifying fetal distress and potentially avoiding medically unnecessary C-sections, which can have short- and long-term implications for the mother and child. The company has developed two innovative technologies, Lumerah™, a low-cost, non-invasive sensor that continuously monitors fetal oxygenation during labor, and Daisy™, a vacuum induced surgical tool for Ob/Gyn applications. Learn more: Raydiantoximetry.com. Public Relations
Raydiant Oximetry Frequently Asked Questions (FAQ)
When was Raydiant Oximetry founded?
Raydiant Oximetry was founded in 2016.
Where is Raydiant Oximetry's headquarters?
Raydiant Oximetry's headquarters is located at 2603 Camino Ramon, San Ramon.
What is Raydiant Oximetry's latest funding round?
Raydiant Oximetry's latest funding round is Grant - II.
How much did Raydiant Oximetry raise?
Raydiant Oximetry raised a total of $24.25M.
Who are the investors of Raydiant Oximetry?
Investors of Raydiant Oximetry include Bill & Melinda Gates Foundation, Cross-Border Impact Ventures, March of Dimes, V Capital, Global Health Impact Network and 23 more.
Who are Raydiant Oximetry's competitors?
Competitors of Raydiant Oximetry include Bloomlife and 7 more.
Loading...
Compare Raydiant Oximetry to Competitors
Baymatob focuses on developing artificial intelligence-guided medical devices for improving health outcomes in obstetrics. The company's main product, Oli, is a labor monitoring device designed to predict and provide early warnings for postpartum hemorrhage, aiming to reduce maternal and infant mortality rates. It primarily serves the healthcare sector, with a focus on maternal health and obstetrics. The company was founded in 2017 and is based in Leichhardt, Australia.
Bloomlife operates as a women's health company focused on improving maternal health through technology in the healthcare sector. The company offers remote patient monitoring and connected devices that provide data analytics for maternal and fetal health, as well as digital health assessments to manage pregnancies. Bloomlife primarily serves healthcare providers and pregnant women. Bloomlife was formerly known as Bloom Technologies. It was founded in 2014 and is based in San Francisco, California.
Marani Health is an AI-powered maternal healthcare technology company focused on improving patient outcomes and enhancing clinical workflows in the healthcare sector. The company offers a platform that delivers individual insights through connected devices, enabling personalized and proactive care for pregnant individuals. Marani Health primarily serves maternity providers, health plans, employers, and patients with its innovative solutions for prenatal and postpartum care. Marani Health was formerly known as Odonata Health. It was founded in 2018 and is based in Oakdale, Minnesota.
Babyscripts is a company focused on improving maternal health outcomes through technology, operating within the healthcare sector. The company offers a risk detection program that includes remote patient monitoring, perinatal education, and mental health assessments to support expectant and new mothers. Babyscripts primarily serves healthcare providers, including hospitals, physicians, midwives, birth centers, and health plans, with virtual tools designed to enhance patient care and outcomes in maternity care. It was founded in 2014 and is based in Washington, DC.
ZyMot Fertility specializes in fertility assistance technology within the healthcare sector. The company offers devices designed to process sperm for use in assisted reproductive technologies. These devices are primarily utilized by healthcare professionals in the fertility industry. It was founded in 2013 and is based in Gaithersburg, Maryland.
Mojo is a company focused on male fertility, operating within the healthcare sector. The company offers at-home sperm testing services, providing full lab analysis results, and consultations with fertility experts. These services aim to help individuals understand and improve their fertility. It was founded in 2017 and is based in Lyon, France.
Loading...